DCGI

'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political Pressure
'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political PressureSwarajya StaffNov 17, 2022 02:09 PM +05:30 IST
Govt Panel Recommends Emergency Use Authorisation For Single-Dose 'Sputnik Light' Covid Vaccine
Govt Panel Recommends Emergency Use Authorisation For Single-Dose 'Sputnik Light' Covid VaccinePTIFeb 5, 2022 08:20 AM +05:30 IST
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review Proposals
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review ProposalsSwarajya StaffJan 15, 2022 03:23 PM +05:30 IST
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTIOct 30, 2021 10:03 AM +05:30 IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Oct 13, 2021 01:00 PM +05:30 IST
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On Children
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On ChildrenIANSSep 2, 2021 12:45 PM +05:30 IST
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical TrialsSwarajya StaffAug 25, 2021 11:00 AM +05:30 IST
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In IndiaSwarajya StaffAug 20, 2021 01:06 PM +05:30 IST
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's VelloreSwarajya StaffAug 11, 2021 11:45 AM +05:30 IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 04:14 PM +05:30 IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 09:29 AM +05:30 IST
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In Trials
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In TrialsSwarajya StaffJul 31, 2021 10:41 AM +05:30 IST
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: ReportSwarajya StaffJul 7, 2021 11:42 AM +05:30 IST
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data FirstSwarajya StaffJul 1, 2021 02:22 PM +05:30 IST
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: ReportSwarajya StaffJun 29, 2021 02:43 PM +05:30 IST
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 PatientsSwarajya StaffJun 12, 2021 02:03 PM +05:30 IST
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In IndiaSwarajya StaffJun 3, 2021 01:04 PM +05:30 IST
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: Report
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: ReportSwarajya StaffJun 2, 2021 12:01 PM +05:30 IST
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas RegulatorsSwarajya StaffJun 2, 2021 11:01 AM +05:30 IST
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19Swarajya StaffMay 27, 2021 12:29 PM +05:30 IST
Load More